Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
BMC Psychiatry ; 22(1): 663, 2022 10 27.
Article in English | MEDLINE | ID: mdl-36303177

ABSTRACT

BACKGROUND: Electroconvulsive therapy (ECT) combined with mood stabilizers is an effective method of treatment for manic episodes; however, there are controversial views on its side effects. CASE PRESENTATION: A 53-year-old man was diagnosed with bipolar disorder during a manic episode, and had previous conditions such as hypertension, and diabetes. He developed reversible delirium and anomic aphasia during combined treatment with lithium and ECT (Li-ECT). No other neurological symptoms or signs happened during the one-month follow-up period. CONCLUSIONS: The anomic aphasia appeared after ECT was reversible. Li-ECT should be administered with caution to middle- and older-aged patients with comorbidities, and serum Li levels should be closely monitored during the treatment period.


Subject(s)
Bipolar Disorder , Electroconvulsive Therapy , Male , Humans , Middle Aged , Electroconvulsive Therapy/adverse effects , Lithium/adverse effects , Anomia/drug therapy , Antimanic Agents/therapeutic use , Bipolar Disorder/therapy , Bipolar Disorder/drug therapy , Treatment Outcome
2.
Rev Neurol ; 60(1): 30-4, 2015 Jan 01.
Article in Spanish | MEDLINE | ID: mdl-25522861

ABSTRACT

INTRODUCTION: There are limited evidences reported of temporal lobe epilepsy associated with active cysticercosis in cystic stage. The objective is to present the correlation between active cysticercosis in topographical zones associated with temporal lobe epilepsy, with neuropsychiatric manifestations and pattern of secondarily generalized partial seizures. CASE REPORTS: Two cases of adult patients with neuropsychiatric manifestations of one year evolution, refractory to antipsychotic drug treatment, and who subsequently appear late onset partial-secondarily generalized seizures. Cysticercosis active presence in the temporal lobe in one patient, and the insula in the other, is identified. A better clinical control after albendazol treatment and subsequently anticonvulsant therapy only remained to evaluate pertinence of pharmacological withdrawal criteria. CONCLUSIONS: Active neurocysticercosis, may be the cause of acquired neuropsychiatric disorders and temporal lobe epilepsy of late onset when the topography is in the mesolimbic circuit. Early etiologic diagnosis and appropriate treatment allows adequate control of their symptoms and potentially final cure.


TITLE: Epilepsia del lobulo temporal y neurocisticercosis activa: dos casos representativos.Introduccion. Existen pocas evidencias notificadas de casos de epilepsia del lobulo temporal asociadas a cisticercosis activa en su fase quistica. El objetivo es presentar la correlacion entre cisticercosis activa en zonas topograficas asociadas a epilepsia del lobulo temporal, con las manifestaciones neuropsiquiatricas y el patron de crisis parciales secundariamente generalizadas. Casos clinicos. Dos casos de pacientes adultos con manifestaciones neuropsiquiatricas de un año de evolucion, refractarios a tratamiento farmacologico antipsicotico, y en quienes posteriormente aparecen crisis convulsivas parciales secundariamente generalizadas de inicio tardio. Se identifica la presencia de cisticercosis activa en el lobulo temporal en un paciente, y en la insula, en el otro. Buen control clinico posterior al tratamiento con albendazol, pero se mantiene el mismo tratamiento anticonvulsionante para considerar la pertinencia de su retirada farmacologica. Conclusiones. La neurocisticercosis activa puede ser causa de trastornos neuropsiquiatricos adquiridos y de epilepsia del lobulo temporal de inicio tardio cuando su topografia se encuentra en el circuito mesolimbico. El diagnostico etiologico oportuno y el tratamiento apropiado permiten el control adecuado de su sintomatologia y, potencialmente, su curacion definitiva.


Subject(s)
Anomia/etiology , Epilepsy, Temporal Lobe/etiology , Neurocysticercosis/complications , Panic Disorder/etiology , Albendazole/therapeutic use , Anomia/drug therapy , Anthelmintics/therapeutic use , Anticonvulsants/therapeutic use , Antipsychotic Agents/therapeutic use , Carbamazepine/analogs & derivatives , Carbamazepine/therapeutic use , Citalopram/therapeutic use , Delayed Diagnosis , Depressive Disorder/drug therapy , Depressive Disorder/etiology , Drug Resistance , Drug Therapy, Combination , Epilepsy, Temporal Lobe/drug therapy , Headache/etiology , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neurocysticercosis/diagnosis , Neurocysticercosis/drug therapy , Neurocysticercosis/psychology , Oxcarbazepine , Panic Disorder/drug therapy , Perphenazine/therapeutic use , Prednisone/therapeutic use
3.
Neurorehabil Neural Repair ; 25(1): 43-7, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20834044

ABSTRACT

BACKGROUND: The effect of levodopa on recovery from aphasia is controversial. OBJECTIVE: To determine whether levodopa enhances the effect of intensive computer-assisted therapy (CAT) of anomia in the postacute stage of aphasia. METHODS: Double-blind multiple case study with intrasubject crossover design comparing the effect of levodopa (100 mg) versus placebo, each given for 2 weeks. SUBJECTS: Twelve patients with onset of aphasia from 2 to 9 weeks after stroke or traumatic brain injury were compared on naming performance on items trained and not trained with CAT. Subjects were randomized to either levodopa or placebo first, separated by a 1-week washout, and then switched to the other drug intervention for the second 2-week CAT intervention. The subjects also received routine aphasia therapies during these periods. RESULTS: All patients improved their naming performance for items trained by CAT in both periods (P = .001). No significant difference was found between the placebo and levodopa phases. CONCLUSION: Administration of levodopa for 2 weeks during the postacute stage of aphasia did not augment the positive effects of subacute intensive language treatment with CAT for a spoken naming task.


Subject(s)
Anomia/drug therapy , Anomia/rehabilitation , Antiparkinson Agents/therapeutic use , Aphasia/drug therapy , Aphasia/rehabilitation , Adult , Aged , Cross-Over Studies , Double-Blind Method , Female , Humans , Language Tests , Levodopa/therapeutic use , Male , Middle Aged , Names , Therapy, Computer-Assisted/methods
4.
Neurocase ; 13(4): 256-9, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17886000

ABSTRACT

Previous research suggests that the noradrenergic system modulates flexibility of access to the lexical-semantic network, with propranolol benefiting normal subjects in lexical-semantic problem solving tasks. Patients with Broca's aphasia with anomia have impaired ability to access appropriate verbal output for a given visual stimulus in a naming task. Therefore, we tested naming in a pilot study of chronic Broca's aphasia patients with anomia after propranolol and after placebo in a double-blinded crossover manner. Naming was better after propranolol than after placebo, suggesting a potential benefit from propranolol in chronic Broca's aphasia with anomia. Larger follow-up studies are necessary to further investigate this effect.


Subject(s)
Adrenergic beta-Antagonists/therapeutic use , Anomia/drug therapy , Aphasia, Broca/drug therapy , Association Learning/drug effects , Names , Propranolol/therapeutic use , Aged , Analysis of Variance , Anomia/etiology , Anomia/physiopathology , Aphasia, Broca/complications , Aphasia, Broca/etiology , Humans , Language Tests , Middle Aged , Neuropsychological Tests , Reaction Time/drug effects , Stroke/complications
5.
J Child Neurol ; 19(1): 53-8, 2004 Jan.
Article in English | MEDLINE | ID: mdl-15032386

ABSTRACT

A 5-year-old boy presented with typical clinical and electrophysiologic features of benign rolandic epilepsy. His neurodevelopment, language, and behavior prior to the onset of epilepsy were appropriately normal. He demonstrated marked deterioration of language and cognitive function during the course to a mild and then a moderate disability range. Serial sleep electroencephalographic recordings initially showed continuous and bilateral rolandic discharges with evolution to localized left rolandic spikes. Language and cognitive improvements were subsequently seen. Educational support and evolution of the electroencephalogram to a localized focus could have been contributory. It is anticipated, however, that he will have significant long-term problems in complex language.


Subject(s)
Cognition Disorders/diagnosis , Dysarthria/diagnosis , Epilepsy, Rolandic/diagnosis , Language Development Disorders/diagnosis , Anomia/diagnosis , Anomia/drug therapy , Anticonvulsants/adverse effects , Anticonvulsants/therapeutic use , Carbamazepine/adverse effects , Carbamazepine/therapeutic use , Cerebral Cortex/drug effects , Child , Child, Preschool , Cognition Disorders/drug therapy , Dose-Response Relationship, Drug , Drug Therapy, Combination , Dysarthria/drug therapy , Electroencephalography/drug effects , Epilepsy, Rolandic/drug therapy , Ethosuximide/adverse effects , Ethosuximide/therapeutic use , Evoked Potentials/drug effects , Follow-Up Studies , Humans , Language Development Disorders/drug therapy , Male , Neuropsychological Tests , Prednisone/administration & dosage , Prednisone/adverse effects , Speech Perception/drug effects , Treatment Outcome , Valproic Acid/adverse effects , Valproic Acid/therapeutic use , Verbal Learning/drug effects
7.
Article in English | MEDLINE | ID: mdl-9297711

ABSTRACT

This study sought to produce a cognitive profile of herpes simplex encephalitis (HSE) survivors from a large group of definitively diagnosed, acyclovir-treated participants. Results from 22 adults who underwent a battery of neuropsychological tests indicated anterograde memory dysfunction to be the most severe and common deficit (although the variation was great), with less severe and less frequent impairments in the areas of retrograde memory, executive functions, and language functioning. Overall, neuropsychological outcome was unimpaired in six participants, mildly impaired in thirteen, moderately impaired in one, severely impaired in two. Older participants and those with a lower level of consciousness before the start of treatment produced poorer scores on certain aspects of cognitive outcome (p < 0.05). A significantly better cognitive outcome was found in participants for whom there was a short delay (fewer than 5 days) between symptom onset and acyclovir treatment compared with those participants for whom there was a longer delay. The two children in the study had disparate results on most tests, the exception being those assessing memory functioning on which both children had scores at population norms. On a naming task designed to explore category-specific knowledge deficits, the adults as a group made more errors on pictures of living things than nonliving things (matched pair-wise for word frequency and visual familiarity), although this difference disappeared on a smaller subset of pictures also matched for visual complexity.


Subject(s)
Brain Damage, Chronic/psychology , Encephalitis, Viral/psychology , Herpes Simplex/psychology , Neuropsychological Tests , Survivors/psychology , Acyclovir/therapeutic use , Adolescent , Adult , Aged , Amnesia/diagnosis , Amnesia/drug therapy , Amnesia/psychology , Anomia/diagnosis , Anomia/drug therapy , Anomia/psychology , Antiviral Agents/therapeutic use , Brain Damage, Chronic/diagnosis , Brain Damage, Chronic/drug therapy , Child , Child, Preschool , Dose-Response Relationship, Drug , Drug Administration Schedule , Encephalitis, Viral/diagnosis , Encephalitis, Viral/drug therapy , Female , Follow-Up Studies , Herpes Simplex/diagnosis , Herpes Simplex/drug therapy , Humans , Male , Middle Aged , New Zealand , Paired-Associate Learning
SELECTION OF CITATIONS
SEARCH DETAIL
...